Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLP-B Inhibitors

Prolactin family 6, subfamily a, member 1, commonly abbreviated as PRL6A1, is a protein encoded by the gene "prolactin family 6, subfamily a, member 1" in humans. This protein belongs to the prolactin family, which is part of a larger group of proteins known as the prolactin/growth hormone/placental lactogen family. These proteins are recognized for their roles in a wide range of biological processes, including lactation, reproduction, growth, and immune regulation.

PRL6A1 is predominantly expressed in the placenta, and similar to other members of the prolactin family, it is hypothesized to play a role in pregnancy and fetal development. The precise function of PRL6A1 remains less characterized compared to the well-studied prolactin or placental lactogen hormones. However, given its structural similarity to these hormones, PRL6A1 is thought to interact with prolactin receptors on the surface of target cells, initiating signaling cascades that can influence cellular growth, differentiation, and metabolic processes.The expression of PRL6A1, along with other prolactin-like proteins, indicates a potential autocrine or paracrine regulatory mechanism within the placenta, which may be important for placental development and function. These proteins could be involved in modulating the maternal immune response to allow for successful fetal implantation and to maintain pregnancy. Additionally, they may contribute to the adaptation of maternal metabolism to meet the demands of the developing fetus.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D inhibits RNA synthesis, potentially impacting the expression of PRL6A1 at the transcriptional level.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide inhibits RNA polymerase and NF-κB, potentially affecting the transcription of PRL6A1 and its regulatory pathways.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits cyclin-dependent kinases, potentially affecting the transcriptional regulation of PRL6A1 and its associated pathways.

Triamcinolone acetonide

76-25-5sc-205872
sc-205872A
50 mg
250 mg
$56.00
$149.00
(0)

Triamcinolone acetonide is a glucocorticoid receptor agonist, and its modulation of transcriptional activity may impact the expression of PRL6A1.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin inhibits RNA polymerase II, potentially impacting the transcription of PRL6A1 and its downstream targets.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor, potentially impacting the epigenetic regulation of PRL6A1 expression.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$142.00
$558.00
4
(1)

Ellipticine is a DNA-intercalating agent, potentially impacting the transcriptional regulation of PRL6A1 and its associated pathways.